Key highlights
No new cases of cVDPV2 were reported this week. The total number of cVDPV2 cases remains 63. All confirmed cases to date have had onset of paralysis before 25 August, 2017
IPV activities aimed at reaching children aged 2-23 months are ongoing. IPV will be offered alongside bOPV as part of the Sub-National Immunization Days (SNIDs) in 6 (six) districts of Damascus and 200 hotels in the city, 3 (three) areas of Rural Damascus, 2 (two) districts of Homs and 1 (one) district of Aleppo with large IDP populations from Deir Ez-Zor
Almost 3,000 children under 5 (five) have received all routine immunization antigens in newly accessible areas of Deir Ez-Zor city between 7-10 November in opportunistic vaccination activities
A joint mission between the World Health Organization and the local Health Authority to visit newly accessible areas of Aleppo was conducted this week. The mission also met with the Aleppo University Hospital and Aleppo Pediatric Association to advocate for AFP surveillance and to support ongoing immunization activities to reach IDPs from infected areas
The Advisory Group on mOPV2 vaccine provision met this week to review the revised risk assessment for Syria cVDPV2 outbreak and discuss contingency plans for outbreak response. The group endorsed, in principle, the proposal to preposition approximately 1 million doses mOPV2 in Damascus (pending receipt of formal vaccine request from the Ministry of Health) to enable rapid response in the event of any ongoing outbreak response activities
